In a study by Zhang et al., USP22 was upregulated in breast cancer samples obtained from patients with aggressive phenotypes compared to benign tumors, and correlated with a decrease in H2Bub1 levels [120]. This evidence concerns the gene USP22 and breast carcinoma.